NCT01920412View on ClinicalTrials.gov

Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

September 30, 2014

Conditions
Atrial FibrillationStroke
Interventions
DEVICE

LAmbre Left Atrial Appendage(LAA) Occluder

Implanting the LAmbre Left Atrial Appendage Occluder to close the left atrial appendage

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY

NCT01920412 - Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder | Biotech Hunter | Biotech Hunter